FIELD: medicine.
SUBSTANCE: invention relates to peptides of general formula 
, and to their cosmetically or dermopharmaceutically acceptable salts, where: X is chosen from the group formed by cysteinyl, seryl, threonyl and aminobutyryl; R1 is chosen from the group formed by H or a saturated linear C2-C24 acyl group; R2 is chosen from the group formed by an amino group optionally substituted with C1-C24 alkyl, or a hydroxy group. Besides the invention covers a method for making said peptides, their cosmetic or dermopharmaceutical compositions intended for reducing or eliminating baggy lower eyelids.
EFFECT: higher effectiveness.
12 cl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDES, APPLIED IN SKIN, MUCOSA AND/OR HAIR TREATMENT AND/OR CARE, AND THEIR APPLICATION IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS | 2010 |
|
RU2557401C2 |
| PEPTIDES INHIBITING NEURON EXOCYTOSIS | 2007 |
|
RU2461568C2 |
| PEPTIDE VECTORS | 2004 |
|
RU2361876C2 |
| OXYTOCIN ANALOGUES | 2009 |
|
RU2496788C2 |
| GLP-1 PEPTIDE HAVING ATTACHED OLIGOSACCHARIDE CHAIN | 2008 |
|
RU2539829C2 |
| INHIBITORS OF VIIA FACTOR | 1999 |
|
RU2223967C2 |
| PRODRUGS CONTAINING HYALURONIC ACID CONJUGATE, LINKER AND DOUBLE AGONIST GLP-1/GLUCAGON | 2016 |
|
RU2719482C2 |
| METHOD FOR CLEAVAGE OF SOLID PHASE-BOUND PEPTIDES FROM THE SOLID PHASE | 2019 |
|
RU2771712C2 |
| METHOD FOR PRODUCING PEPTIDE EXENATIDE | 2011 |
|
RU2458066C1 |
| CHIMERIC ANALOGS OF SOMATOSTATIN-DOPAMINE | 2002 |
|
RU2277539C2 |
